


                   Lunai Bioworks (LNAI) Statistics & Valuation














     Skip to main content     /    Log In Sign Up  Home Watchlist Stocks  Stock ScreenerStock ExchangesComparison ToolEarnings CalendarBy IndustryStock ListsTop AnalystsTop StocksCorporate Actions IPOs  Recent IPOsIPO CalendarIPO StatisticsIPO NewsIPO Screener ETFs  ETF ScreenerComparison ToolNew LaunchesETF Providers News Trending Articles Technical Chart Market Movers  Top GainersTop LosersMost ActivePremarketAfter HoursMarket Heatmap Market Newsletter Stock Analysis Pro  Collapse  Light  Dark  Sign Up Log In  Lunai Bioworks Inc. (LNAI) NASDAQ: LNAI · Real-Time Price · USD   Watchlist  Compare 1.500 +0.340 (29.31%) At close: Nov 19, 2025, 4:00 PM EST 1.380 -0.120 (-8.00%)  After-hours: Nov 19, 2025, 4:10 PM EST Overview Financials  Statistics   History Profile Chart  Statistics Market Cap  Lunai Bioworks Statistics Total Valuation Lunai Bioworks has a market cap or net worth of $34.88 million. The enterprise value is $28.97 million. Market Cap34.88MEnterprise Value 28.97M Important Dates The last earnings date was Friday, November 14, 2025, after market close. Earnings Date Nov 14, 2025Ex-Dividend Date n/a Share Statistics Lunai Bioworks has 23.18 million shares outstanding. The number of shares has increased by 49.41% in one year. Current Share Class 23.18MShares Outstanding 23.18MShares Change (YoY) +49.41%Shares Change (QoQ) +27.87%Owned by Insiders (%) 30.77%Owned by Institutions (%) 5.01%Float 13.70M  Valuation Ratios  PE Ratio n/aForward PE n/aPS Ratio n/aForward PS n/aPB Ratio n/aP/TBV Ratio n/aP/FCF Ratio n/aP/OCF Ratio n/aPEG Ratio n/a Financial Ratio History Enterprise Valuation  EV / Earnings n/aEV / Sales n/aEV / EBITDA n/aEV / EBIT n/aEV / FCF n/a Financial Position The company has a current ratio of 0.04 Current Ratio 0.04Quick Ratio 0.03Debt / Equity n/aDebt / EBITDA n/aDebt / FCF n/aInterest Coverage -25.58  Financial Efficiency Return on equity (ROE) is -308.01% and return on invested capital (ROIC) is -20.86%. Return on Equity (ROE) -308.01%Return on Assets (ROA) -14.85%Return on Invested Capital (ROIC) -20.86%Return on Capital Employed (ROCE) 119.88%Revenue Per Employee n/aProfits Per Employee -$4.52MEmployee Count29Asset Turnover n/aInventory Turnover n/a Taxes  Income Tax n/aEffective Tax Rate n/a Stock Price Statistics The stock price has decreased by -70.03% in the last 52 weeks. The beta is 0.39, so Lunai Bioworks's price volatility has been lower than the market average. Beta (5Y) 0.3952-Week Price Change -70.03%50-Day Moving Average 1.26200-Day Moving Average 3.55Relative Strength Index (RSI) 65.10Average Volume (20 Days) 9,113,403 Short Selling Information  Short Interest n/aShort Previous Month n/aShort % of Shares Out n/aShort % of Float n/aShort Ratio (days to cover) n/a Income Statement  Revenue n/aGross Profit n/aOperating Income -15.30MPretax Income -130.98MNet Income -130.98MEBITDA -15.16MEBIT -15.30MEarnings Per Share (EPS) -$7.22 Full Income Statement Balance Sheet The company has $624,808 in cash and $2.71 million in debt, giving a net cash position of -$2.08 million or -$0.09 per share. Cash & Cash Equivalents 624,808Total Debt 2.71MNet Cash -2.08MNet Cash Per Share -$0.09Equity (Book Value) -13.04MBook Value Per Share -0.56Working Capital -18.92M Full Balance Sheet Cash Flow  Operating Cash Flow -7.21MCapital Expenditures n/aFree Cash Flow -7.21MFCF Per Share -$0.31 Full Cash Flow Statement Margins  Gross Margin n/aOperating Margin n/aPretax Margin n/aProfit Margin n/aEBITDA Margin n/aEBIT Margin n/aFCF Margin n/a Dividends & Yields Lunai Bioworks does not appear to pay any dividends at this time. Dividend Per Share n/aDividend Yield n/aDividend Growth (YoY) n/aYears of Dividend Growth n/aPayout Ratio n/aBuyback Yield -49.41%Shareholder Yield -49.41%Earnings Yield -487.14%FCF Yield -26.81%        Analyst Forecast  Price Target n/aPrice Target Difference n/aAnalyst Consensus n/aAnalyst Count n/aRevenue Growth Forecast (5Y) n/aEPS Growth Forecast (5Y) n/a  Fair Value There are several formulas that can be used to estimate the intrinsic value of a stock. Lynch Fair Value n/aLynch Upside n/aGraham Number n/aGraham Upside n/a Stock Splits The last stock split was on September 30, 2025. It was a reverse split with a ratio of 1:10. Last Split Date Sep 30, 2025Split Type ReverseSplit Ratio 1:10 Scores  Altman Z-Score n/aPiotroski F-Score 1         Sections Stocks IPOs ETFs Blog Services Stock Analysis Pro Free Newsletter Get Support Install The App Website Login Create Account Changelog Sitemap Advertise FAQ Company About Contact Us Terms of Use Privacy Policy Data Disclaimer Affiliate Program   Market Newsletter Daily market news in bullet point format.  Subscribe Site Theme  Light  Dark    © 2025 StockAnalysis.com. All rights reserved.    


